David Wald

Company: Case Western Reserve University

Job title: Associate Professor

Seminars:

Exploring TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin’s Lymphoma 2:30 pm

• Demonstrating that TIGIT is induced on CAR-T cells after infusion into lymphoma patients • Highlighting how TIGIT blockade can enhance the efficacy of CD19 CAR-T cells in animal models of human lymphomaRead more

day: Day One

TIGIT: One Target with Multiple Ligands & Key Players 2:30 pm

• Providing an up-to-date review of key potential biomarkers • Designing smarter trials using relevant biomarkers • Utilizing new technologies to harness the power of key biomarkersRead more

day: Day One